Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression
Status:
Withdrawn
Trial end date:
2017-04-30
Target enrollment:
Participant gender:
Summary
This proposed research is aimed to investigate the efficacy and safety of combined cytidine-
and creatine-containing drug and dietary supplement in treating bipolar depression and to
evaluate changes in relevant brain biochemical metabolism using magnetic resonance
spectroscopy.
Phase:
Phase 2
Details
Lead Sponsor:
Ewha Womans University Seoul National University Hospital